NATURE’S SUNSHINE PRODUCTS, INC. Foreign Currency Transaction Gain (Loss), before Tax
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Foreign Currency Transaction Gain (Loss), before Tax of -$223.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-08-06
- NATURE’S SUNSHINE PRODUCTS, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2026-06-30 was -$223.00K, a 107.37% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2026-03-31 was -$1.43M, a 289.77% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2025-12-31 was $71.00K.
- NATURE’S SUNSHINE PRODUCTS, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2025-09-30 was $672.00K, a 74.68% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. foreign currency transaction gain (loss), before tax for fiscal 2025 was $4.52M.
- NATURE’S SUNSHINE PRODUCTS, INC. foreign currency transaction gain (loss), before tax for fiscal 2024 was -$1.70M, a 275.26% decline from fiscal 2023.
- NATURE’S SUNSHINE PRODUCTS, INC. foreign currency transaction gain (loss), before tax for fiscal 2023 was $970.00K.
- NATURE’S SUNSHINE PRODUCTS, INC. foreign currency transaction gain (loss), before tax for fiscal 2022 was -$917.00K.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$223.00K 10-Q · filed 2026-08-06 | -$1.65M 10-Q · filed 2026-08-06 | -$1.58M derived: sum of 3 quarters · filed 2026-08-06 | -$909.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | -$1.43M 10-Q · filed 2026-05-07 | -$1.36M derived: sum of 2 quarters · filed 2026-05-07 | -$686.00K derived: sum of 3 quarters · filed 2026-05-07 | $2.34M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $71.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $743.00K derived: sum of 2 quarters · filed 2026-03-10 | $3.77M derived: sum of 3 quarters · filed 2026-08-06 | $4.52M 10-K · filed 2026-03-10 | |
| 2025-09-30 | $672.00K 10-Q · filed 2025-11-06 | $3.70M derived: sum of 2 quarters · filed 2026-08-06 | $4.45M 10-Q · filed 2025-11-06 | $1.64M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $3.03M 10-Q · filed 2026-08-06 | $3.78M 10-Q · filed 2026-08-06 | $968.00K derived: sum of 3 quarters · filed 2026-08-06 | $3.62M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $753.00K 10-Q · filed 2026-05-07 | -$2.06M derived: sum of 2 quarters · filed 2026-05-07 | $596.00K derived: sum of 3 quarters · filed 2026-05-07 | -$927.00K derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | -$2.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$157.00K derived: sum of 2 quarters · filed 2026-03-10 | -$1.68M derived: sum of 3 quarters · filed 2026-03-10 | -$1.70M 10-K · filed 2026-03-10 | |
| 2024-09-30 | $2.65M 10-Q · filed 2025-11-06 | $1.13M derived: sum of 2 quarters · filed 2025-11-06 | $1.11M 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | -$1.52M 10-Q · filed 2025-07-31 | -$1.54M 10-Q · filed 2025-07-31 | |||
| 2024-03-31 | -$20.00K 10-Q · filed 2025-05-06 | ||||
| 2023-12-31 | $970.00K 10-K · filed 2025-03-11 | ||||
| 2022-12-31 | -$917.00K 10-K · filed 2024-03-12 | ||||
| 2021-12-31 | -$3.06M 10-K · filed 2023-03-16 | ||||
| 2020-12-31 | $1.27M 10-K · filed 2022-03-08 | ||||
| 2019-12-31 | -$702.00K 10-K · filed 2021-03-10 | ||||
| 2018-12-31 | -$1.70M 10-K · filed 2020-03-11 | ||||
| 2017-12-31 | $1.98M 10-K · filed 2019-03-08 | ||||
| 2016-12-31 | -$1.35M 10-K · filed 2019-03-08 | ||||
| 2015-12-31 | -$1.95M 10-K · filed 2018-03-16 | ||||
| 2014-12-31 | $225.00K 10-K · filed 2017-03-14 | ||||
| 2013-12-31 | $1.39M 10-K · filed 2016-03-14 | $1.25M 10-K · filed 2014-03-17 | |||
| 2012-12-31 | $290.00K 10-K · filed 2015-03-13 | ||||
| 2011-12-31 | $466.00K 10-K · filed 2014-03-17 | ||||
| 2010-12-31 | $2.46M 10-K · filed 2013-03-07 | ||||
| 2009-12-31 | $1.01M 10-K · filed 2012-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |